Hrt Financial LP Ascendis Pharma A/S Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$69.96 - $97.84 $76,256 - $106,645	1,090 Added 43.19%	3,614 $322,000
Q1 2023 May 12, 2023	BUY	$104.9 - $126.78 $264,767 - $319,992	2,524 New	2,524 $270,000
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $1.41 Million - $2.21 Million	-12,495 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$121.62 - $145.29 $1.52 Million - $1.82 Million	12,495 New	12,495 $1.64 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.